Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 30 August, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 509472 | NSE: CRAVATEX

Cravatex Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 1:14 pm

Market Cap 113 Cr.
Current Price 437
High / Low 619/310
Stock P/E38.0
Book Value 412
Dividend Yield2.86 %
ROCE6.57 %
ROE4.68 %
Face Value 10.0
PEG Ratio0.26

Quick Insight

Cravatex Ltd's current share price of 436 indicates a market capitalization of 112 Cr., with a relatively high P/E ratio of 37.9. Despite a low ROE of 4.68% and ROCE of 6.57%, the company shows resilience with a Net Profit of 5 Cr. and healthy reserves of 104 Cr. Furthermore, its low P/BV ratio of 0.83x suggests potential undervaluation. However, the negative operating profit margin of -26.42% raises concerns about operational efficiency. With no borrowings and a comfortable interest coverage ratio of 20.39x, Cravatex Ltd's liquidity position appears stable, as evidenced by its Cash Conversion Cycle of 47 days. Overall, while the company's financial health seems robust, improving operational efficiency could be key to unlocking greater shareholder value in the future.

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Cravatex Ltd

Competitors of Cravatex Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Minal Industries Ltd 74.6 Cr. 3.89 5.59/3.2044.4 2.770.00 %5.97 %2.83 % 2.00
Mitshi India Ltd 13.6 Cr. 15.4 19.5/13.0452 3.090.00 %0.36 %0.37 % 10.0
Modella Woollens Ltd 6.32 Cr. 69.4 80.0/52.5 3.630.00 %%% 10.0
MRC Agrotech Ltd 62.5 Cr. 30.5 32.5/10.261.8 15.00.00 %5.89 %4.46 % 10.0
MRP Agro Ltd 112 Cr. 101 174/84.415.1 29.30.00 %39.2 %30.3 % 10.0
Industry Average9,580.23 Cr173.21101.02113.470.27%15.65%9.14%7.74

All Competitor Stocks of Cravatex Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 162.40170.4287.1083.7456.6057.4537.9050.6825.7855.0432.4360.5223.13
Expenses 166.43176.91103.6387.0356.4259.6241.6952.5628.1153.0334.3060.0129.24
Operating Profit -4.03-6.49-16.53-3.290.18-2.17-3.79-1.88-2.332.01-1.870.51-6.11
OPM % -2.48%-3.81%-18.98%-3.93%0.32%-3.78%-10.00%-3.71%-9.04%3.65%-5.77%0.84%-26.42%
Other Income 1.502.52107.576.591.586.035.822.683.482.142.242.095.21
Interest 3.694.863.511.310.080.080.130.110.110.110.110.090.09
Depreciation 3.948.852.910.440.470.530.490.390.340.340.400.400.38
Profit before tax -10.16-17.6884.621.551.213.251.410.300.703.70-0.142.11-1.37
Tax % 9.25%8.54%-0.90%-147.74%64.46%4.00%43.97%-70.00%30.00%28.38%-278.57%31.75%0.73%
Net Profit -11.11-19.1885.383.840.423.110.790.500.482.650.251.44-1.37
EPS in Rs -42.99-74.22330.3914.861.6312.033.061.931.8610.250.975.57-5.30

Last Updated: August 19, 2025, 8:35 pm

Below is a detailed analysis of the quarterly data for Cravatex Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 23.13 Cr.. The value appears to be declining and may need further review. It has decreased from 60.52 Cr. (Mar 2025) to 23.13 Cr., marking a decrease of 37.39 Cr..
  • For Expenses, as of Jun 2025, the value is 29.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 60.01 Cr. (Mar 2025) to 29.24 Cr., marking a decrease of 30.77 Cr..
  • For Operating Profit, as of Jun 2025, the value is -6.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.51 Cr. (Mar 2025) to -6.11 Cr., marking a decrease of 6.62 Cr..
  • For OPM %, as of Jun 2025, the value is -26.42%. The value appears to be declining and may need further review. It has decreased from 0.84% (Mar 2025) to -26.42%, marking a decrease of 27.26%.
  • For Other Income, as of Jun 2025, the value is 5.21 Cr.. The value appears strong and on an upward trend. It has increased from 2.09 Cr. (Mar 2025) to 5.21 Cr., marking an increase of 3.12 Cr..
  • For Interest, as of Jun 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.09 Cr..
  • For Depreciation, as of Jun 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.40 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 0.02 Cr..
  • For Profit before tax, as of Jun 2025, the value is -1.37 Cr.. The value appears to be declining and may need further review. It has decreased from 2.11 Cr. (Mar 2025) to -1.37 Cr., marking a decrease of 3.48 Cr..
  • For Tax %, as of Jun 2025, the value is 0.73%. The value appears to be improving (decreasing) as expected. It has decreased from 31.75% (Mar 2025) to 0.73%, marking a decrease of 31.02%.
  • For Net Profit, as of Jun 2025, the value is -1.37 Cr.. The value appears to be declining and may need further review. It has decreased from 1.44 Cr. (Mar 2025) to -1.37 Cr., marking a decrease of 2.81 Cr..
  • For EPS in Rs, as of Jun 2025, the value is -5.30. The value appears to be declining and may need further review. It has decreased from 5.57 (Mar 2025) to -5.30, marking a decrease of 10.87.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 8:03 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 244232255266356718865532594504203174171
Expenses 230218249271361694843543592533210175177
Operating Profit 13146-5-62421-112-30-8-2-5
OPM % 5%6%2%-2%-2%3%2%-2%0%-6%-4%-1%-3%
Other Income 43344451310118161012
Interest 81013115614151414000
Depreciation 34336615171616212
Profit before tax 73-7-15-1217-2-30-1958664
Tax % 27%28%8%-9%2%37%95%3%7%-1%22%24%
Net Profit 52-8-14-1211-5-31-2059553
EPS in Rs 18.889.25-30.65-53.67-47.7541.25-18.23-118.45-76.97228.0418.6918.6911.49
Dividend Payout % 18%22%0%0%-2%5%-16%-3%-4%1%16%67%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-60.00%-500.00%-75.00%14.29%191.67%-145.45%-520.00%35.48%395.00%-91.53%0.00%
Change in YoY Net Profit Growth (%)0.00%-440.00%425.00%89.29%177.38%-337.12%-374.55%555.48%359.52%-486.53%91.53%

Cravatex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:-3%
5 Years:-27%
3 Years:-34%
TTM:0%
Compounded Profit Growth
10 Years:7%
5 Years:25%
3 Years:31%
TTM:-39%
Stock Price CAGR
10 Years:5%
5 Years:5%
3 Years:3%
1 Year:-22%
Return on Equity
10 Years:%
5 Years:%
3 Years:-16%
Last Year:5%

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:30 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 333333333333
Reserves 40413319717-4-31-529096104
Borrowings 676672135105117202155167000
Other Liabilities 5154676394163241259247442634
Total Liabilities 160164175220208299442385365137125141
Fixed Assets 292928534848927662899
CWIP 000000000000
Investments 000061251555816
Other Assets 131135147167155250325294298124108116
Total Assets 160164175220208299442385365137125141

Below is a detailed analysis of the balance sheet data for Cravatex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
  • For Reserves, as of Mar 2025, the value is 104.00 Cr.. The value appears strong and on an upward trend. It has increased from 96.00 Cr. (Mar 2024) to 104.00 Cr., marking an increase of 8.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2024) to 34.00 Cr., marking an increase of 8.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 141.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 125.00 Cr. (Mar 2024) to 141.00 Cr., marking an increase of 16.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
  • For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
  • For Investments, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 8.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2024) to 116.00 Cr., marking an increase of 8.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Mar 2024) to 141.00 Cr., marking an increase of 16.00 Cr..

Notably, the Reserves (104.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +0035-13-532-4-8144193
Cash from Investing Activity +00-24-43-37211442-1-1
Cash from Financing Activity +0038-34-037-21-4-168-0-1
Net Cash Flow0050-51-232-4318172

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-54.00-52.00-66.00-140.00-111.00-93.00-181.00-166.00-165.00-30.00-8.00-2.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days1131151068410676729882192550
Inventory Days87124124845360498584292840
Days Payable616671658916252336212543
Cash Conversion Cycle1391731591027012095160130272847
Working Capital Days354220-44027102429161519
ROCE %15%12%5%-3%-6%18%6%-6%-2%-24%7%7%

Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 18.6818.68228.05-76.96-118.45
Diluted EPS (Rs.) 18.6818.68228.05-76.96-118.45
Cash EPS (Rs.) 24.4025.97290.52-13.62-50.96
Book Value[Excl.RevalReserv]/Share (Rs.) 411.83382.02357.4298.58181.71
Book Value[Incl.RevalReserv]/Share (Rs.) 411.83382.02357.4298.58181.71
Revenue From Operations / Share (Rs.) 672.41784.121948.992299.882058.19
PBDIT / Share (Rs.) 31.9432.66-69.1643.747.78
PBIT / Share (Rs.) 26.2225.37-131.63-19.60-59.71
PBT / Share (Rs.) 24.6623.84225.73-71.76-115.13
Net Profit / Share (Rs.) 18.6818.68228.05-76.96-118.45
NP After MI And SOA / Share (Rs.) 18.6818.68228.05-76.95-118.45
PBDIT Margin (%) 4.754.16-3.541.900.37
PBIT Margin (%) 3.903.23-6.75-0.85-2.90
PBT Margin (%) 3.663.0411.58-3.12-5.59
Net Profit Margin (%) 2.772.3811.70-3.34-5.75
NP After MI And SOA Margin (%) 2.772.3811.70-3.34-5.75
Return on Networth / Equity (%) 4.534.8963.800.000.00
Return on Capital Employeed (%) 6.186.42-36.18-3.18-9.16
Return On Assets (%) 3.433.8743.12-5.45-7.94
Long Term Debt / Equity (X) 0.000.000.00-2.14-2.98
Total Debt / Equity (X) 0.000.000.00-3.36-5.47
Asset Turnover Ratio (%) 1.311.550.010.010.01
Current Ratio (X) 4.225.112.951.431.39
Quick Ratio (X) 3.864.642.270.971.00
Interest Coverage Ratio (X) 20.3921.30-1.340.830.14
Interest Coverage Ratio (Post Tax) (X) 12.9313.18-2.50-0.47-1.14
Enterprise Value (Cr.) 13.0936.9226.37297.69268.76
EV / Net Operating Revenue (X) 0.070.180.050.500.50
EV / EBITDA (X) 1.594.37-1.4826.34133.65
MarketCap / Net Operating Revenue (X) 0.500.550.160.150.14
Price / BV (X) 0.831.140.89-1.87-2.65
Price / Net Operating Revenue (X) 0.500.550.160.150.14
EarningsYield 0.050.040.71-0.21-0.40

After reviewing the key financial ratios for Cravatex Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 18.68. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 18.68.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 18.68. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 18.68.
  • For Cash EPS (Rs.), as of Mar 25, the value is 24.40. This value is within the healthy range. It has decreased from 25.97 (Mar 24) to 24.40, marking a decrease of 1.57.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 411.83. It has increased from 382.02 (Mar 24) to 411.83, marking an increase of 29.81.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 411.83. It has increased from 382.02 (Mar 24) to 411.83, marking an increase of 29.81.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 672.41. It has decreased from 784.12 (Mar 24) to 672.41, marking a decrease of 111.71.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 31.94. This value is within the healthy range. It has decreased from 32.66 (Mar 24) to 31.94, marking a decrease of 0.72.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 26.22. This value is within the healthy range. It has increased from 25.37 (Mar 24) to 26.22, marking an increase of 0.85.
  • For PBT / Share (Rs.), as of Mar 25, the value is 24.66. This value is within the healthy range. It has increased from 23.84 (Mar 24) to 24.66, marking an increase of 0.82.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 18.68. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 18.68.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.68. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 18.68.
  • For PBDIT Margin (%), as of Mar 25, the value is 4.75. This value is below the healthy minimum of 10. It has increased from 4.16 (Mar 24) to 4.75, marking an increase of 0.59.
  • For PBIT Margin (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 10. It has increased from 3.23 (Mar 24) to 3.90, marking an increase of 0.67.
  • For PBT Margin (%), as of Mar 25, the value is 3.66. This value is below the healthy minimum of 10. It has increased from 3.04 (Mar 24) to 3.66, marking an increase of 0.62.
  • For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 2.38 (Mar 24) to 2.77, marking an increase of 0.39.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 8. It has increased from 2.38 (Mar 24) to 2.77, marking an increase of 0.39.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 15. It has decreased from 4.89 (Mar 24) to 4.53, marking a decrease of 0.36.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 10. It has decreased from 6.42 (Mar 24) to 6.18, marking a decrease of 0.24.
  • For Return On Assets (%), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 5. It has decreased from 3.87 (Mar 24) to 3.43, marking a decrease of 0.44.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has decreased from 1.55 (Mar 24) to 1.31, marking a decrease of 0.24.
  • For Current Ratio (X), as of Mar 25, the value is 4.22. This value exceeds the healthy maximum of 3. It has decreased from 5.11 (Mar 24) to 4.22, marking a decrease of 0.89.
  • For Quick Ratio (X), as of Mar 25, the value is 3.86. This value exceeds the healthy maximum of 2. It has decreased from 4.64 (Mar 24) to 3.86, marking a decrease of 0.78.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 20.39. This value is within the healthy range. It has decreased from 21.30 (Mar 24) to 20.39, marking a decrease of 0.91.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.93. This value is within the healthy range. It has decreased from 13.18 (Mar 24) to 12.93, marking a decrease of 0.25.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 13.09. It has decreased from 36.92 (Mar 24) to 13.09, marking a decrease of 23.83.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.07, marking a decrease of 0.11.
  • For EV / EBITDA (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 5. It has decreased from 4.37 (Mar 24) to 1.59, marking a decrease of 2.78.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.50, marking a decrease of 0.05.
  • For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 1.14 (Mar 24) to 0.83, marking a decrease of 0.31.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.50, marking a decrease of 0.05.
  • For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Cravatex Ltd as of August 30, 2025 is: 602.92

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of August 30, 2025, Cravatex Ltd is Undervalued by 37.97% compared to the current share price 437.00

Intrinsic Value of Cravatex Ltd as of August 30, 2025 is: 1,481.10

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of August 30, 2025, Cravatex Ltd is Undervalued by 238.92% compared to the current share price 437.00

Last 5 Year EPS CAGR: 145.66%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of 22.75, which is a positive sign.
  2. The company has shown consistent growth in sales (393.38 cr) and profit (1.23 cr) over the years.
  1. The stock has a low average ROCE of 2.42%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 104.17, which may not be favorable.
  3. The company has higher borrowings (90.50) compared to reserves (30.00), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cravatex Ltd:
    1. Net Profit Margin: 2.77%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 6.18% (Industry Average ROCE: 15.65%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 4.53% (Industry Average ROE: 9.14%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 12.93
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.86
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 38 (Industry average Stock P/E: 101.02)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Cravatex Ltd. is a Public Limited Listed company incorporated on 22/06/1951 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L93010MH1951PLC008546 and registration number is 008546. Currently Company is involved in the business activities of Real estate activities with own or leased property. Company's Total Operating Revenue is Rs. 4.80 Cr. and Equity Capital is Rs. 2.58 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Trading & Distributors1st Floor, Godrej Bhavan, 4A Home Street Mumbai Maharashtra 400001investors@cravatex.com
http://www.cravatex.com
Management
NamePosition Held
Mr. Rajesh BatraChairman & Managing Director
Mr. Divakar G KamathExecutive Director & CFO
Mr. Rohan BatraNon Executive Director
Mr. Pheroza Jimmy BilimoriaIndependent Director
Mr. Satyan Shivkumar IsraniIndependent Director
Mr. Nakul ToshniwalIndependent Director
Ms. Rina Suresh DeoraIndependent Director

FAQ

What is the intrinsic value of Cravatex Ltd?

Cravatex Ltd's intrinsic value (as of 29 August 2025) is 602.92 which is 37.97% higher the current market price of ₹437.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹113 Cr. market cap, FY2025-2026 high/low of 619/310, reserves of ₹104 Cr, and liabilities of 141 Cr.

What is the Market Cap of Cravatex Ltd?

The Market Cap of Cravatex Ltd is 113 Cr..

What is the current Stock Price of Cravatex Ltd as on 29 August 2025?

The current stock price of Cravatex Ltd as on 29 August 2025 is 437.

What is the High / Low of Cravatex Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Cravatex Ltd stocks is 619/310.

What is the Stock P/E of Cravatex Ltd?

The Stock P/E of Cravatex Ltd is 38.0.

What is the Book Value of Cravatex Ltd?

The Book Value of Cravatex Ltd is 412.

What is the Dividend Yield of Cravatex Ltd?

The Dividend Yield of Cravatex Ltd is 2.86 %.

What is the ROCE of Cravatex Ltd?

The ROCE of Cravatex Ltd is 6.57 %.

What is the ROE of Cravatex Ltd?

The ROE of Cravatex Ltd is 4.68 %.

What is the Face Value of Cravatex Ltd?

The Face Value of Cravatex Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Cravatex Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE